Capital World Investors’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
RCM
HA
Capital World Investors's LEGN Position: Q2 2024 in Review
Capital World Investors sold out of Legend Biotech (LEGN) in Q2 2024, closing a stake of 2,385,960 shares — an estimated $134M sold.
Capital World Investors first reported a position in LEGN in Q2 2020 and held it in 16 quarters. The position peaked at $165M in Q2 2023. 181 funds tracked by Wall St. Rank hold LEGN as of Q2 2024.
- Capital World Investors reported no remaining Legend Biotech position as of Q2 2024 after selling out during the quarter.
- Capital World Investors sold 2,385,960 Legend Biotech shares in Q2 2024, an estimated $134M.
- Capital World Investors first reported a position in Legend Biotech in Q2 2020 and held it in 16 quarters.
- Capital World Investors's Legend Biotech position peaked at $165M in Q2 2023.
- 181 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2024.
Based on Capital World Investors's 13F filing for Q2 2024, filed 13 Aug 2024.